Trials / Recruiting
RecruitingNCT07195032
Safety and Efficacy of Measles, Mumps, Rubella Vaccination in Pediatric Heart Transplantation Patients
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Children's Mercy Hospital Kansas City · Academic / Other
- Sex
- All
- Age
- 1 Year – 17 Years
- Healthy volunteers
- Not accepted
Summary
The study is an interventional, non-randomized assessment of safety and efficacy of live Measles, Mumps and Rubella (MMR) vaccine in subjects aged 12-months to 17 years who have undergone heart transplantation. Subjects who provide permission/assent will receive the commercial MMR vaccine according to product indication and labeling.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Commercial measles, mumps, and rubella (MMR) vaccine | Participants will receive the commercial MMR vaccine if they are deemed eligible for the study. |
Timeline
- Start date
- 2025-09-11
- Primary completion
- 2027-09-11
- Completion
- 2027-09-11
- First posted
- 2025-09-26
- Last updated
- 2025-09-26
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07195032. Inclusion in this directory is not an endorsement.